Showing results (491-500 of 578) with videos related to
Sort By:
Pageof 58
Endocrine-Related Cancer|July 15, 2016
Ki-67 index and response to chemotherapy in patients with neuroendocrine tumoursAlexa Childs, Amy Kirkwood, Julien Edeline, et al.The Journal of Clinical Investigation|June 1, 2021
Mild COVID-19 despite autoantibodies against type I IFNs in autoimmune polyendocrine syndrome type 1Christian Meisel, Bengisu Akbil, Tim Meyer, et al.Journal of Molecular Biology|July 29, 2008
Engineering a single-chain Fv antibody to alpha v beta 6 integrin using the specificity-determining loop of a foot-and-mouth disease virusHeide Kogelberg, Berend Tolner, Gareth J Thomas, et al.JAMA Oncology|October 5, 2023
Tislelizumab vs Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Phase 3 Randomized Clinical TrialShukui Qin, Masatoshi Kudo, Tim Meyer, et al.Archives of General Psychiatry|February 4, 2010
Hippocampal plasticity in response to exercise in schizophreniaFrank-Gerald Pajonk, Thomas Wobrock, Oliver Gruber, et al.Frontiers in Genetics|November 8, 2021
Development and Implementation of In-House Pharmacogenomic Testing Program at a Major Academic Health SystemPawel Mroz, Stephen Michel, Josiah D Allen, et al.European Journal of Cancer (Oxford, England : 1990)|January 22, 2014
Capecitabine and streptozocin ± cisplatin in advanced gastroenteropancreatic neuroendocrine tumoursTim Meyer, Wendi Qian, Martyn E Caplin, et al.British Journal of Cancer|October 8, 2021
Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin gradeRobin Kate Kelley, Rebecca Miksad, Irfan Cicin, et al.Neuroendocrinology|September 20, 2020
Understanding the Treatment Algorithm of Patients with Metastatic Pancreatic Neuroendocrine Neoplasms: A Single-Institution Retrospective Analysis Comparing Outcomes of Chemotherapy, Molecular Targeted Therapy, and Peptide Receptor Radionuclide Therapy in 255 PatientsAimee R Hayes, Ingrid Y F Mak, Nicholas Evans, et al.Hepatology Communications|March 8, 2021
A Real-World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET-HCCRoniel Cabrera, Amit G Singal, Massimo Colombo, et al.Pageof 58